HSV-pneumonitis in a patient with lung cancer receiving check point inhibitors - a case report.
Johannes SumerFrederike WaldeckNadja FischerChristina AppenzellerMarkus KosterMartin FrühWerner C AlbrichPublished in: Pneumonia (Nathan Qld.) (2021)
We report an unusual case of fatal HSV-1 pneumonitis due to reactivation in a patient with lung cancer, steroid-induced diabetes and treatment with two checkpoint inhibitors. In immunosuppressed patients with non-improving pneumonia invasive diagnostic procedures are warranted including cytology and molecular diagnostics.